Placenta
Volume 29, Supplement , Pages 10-16, March 2008

Human Embryonic Stem Cells as Models for Trophoblast Differentiation

  • L.C. Schulz

      Affiliations

    • Division of Animal Sciences, University of Missouri-Columbia, Columbia, MO 65211, USA
    • ,
  • T. Ezashi

      Affiliations

    • Division of Animal Sciences, University of Missouri-Columbia, Columbia, MO 65211, USA
    • ,
  • P. Das

      Affiliations

    • Division of Animal Sciences, University of Missouri-Columbia, Columbia, MO 65211, USA
    • ,
  • S.D. Westfall

      Affiliations

    • Division of Animal Sciences, University of Missouri-Columbia, Columbia, MO 65211, USA
    • ,
  • K.A. Livingston

      Affiliations

    • Division of Animal Sciences, University of Missouri-Columbia, Columbia, MO 65211, USA
    • ,
  • R.M. Roberts

      Affiliations

    • Division of Animal Sciences, University of Missouri-Columbia, Columbia, MO 65211, USA
    • Division of Biochemistry, University of Missouri-Columbia, Columbia, MO 65211, USA
    • Corresponding Author InformationCorresponding author. Division of Animal Sciences, University of Missouri-Columbia, 240b Bond Life Sciences Center, 1201 E. Rollins Street, Columbia, MO 65211, USA. Tel.: +1 573 882 0908; fax: +1 573 884 9676.

Accepted 24 October 2007. published online 04 December 2007.

Article Outline

Abstract 

Trophectoderm is specified from pluripotent blastomeres at some time prior to blastocyst formation. Proliferating cytotrophoblast derived from trophectoderm is the forerunner of the entire trophoblast component of the mature human placenta, including extravillous cytotrophoblast and syncytiotrophoblast. Recently human embryonic stem cells (hESC) have been employed to study these events in an in vitro situation. Here we review some of the work in this emerging area of trophoblast biology. We concentrate primarily on a model in which colonies of hESC are exposed to BMP4 in stem cell growth medium lacking FGF2. Under both low (4%) and high (20%) O2 conditions, differentiation proceeds unidirectionally towards trophoblast from the outside of the colonies inwards, with the progression fastest under high O2. Immunohistochemical observations performed on whole colonies combined with microarray analysis of mRNA can be employed to track developmental transitions as they occur over time and in two-dimensional space as the cells respond to BMP4.

Keywords: Bone morphogenetic protein-4, Extravillous cytotrophoblast, Human embryonic stem cell, Oxygen, Syncytiotrophoblast

 

Back to Article Outline

1. Introduction: the trophoblast lineage and its emergence 

Trophectoderm, the precursor of placental trophoblast, becomes apparent as the blastocoel cavity forms and expands and provides the first visual evidence of separation of cell lineages during the development of the mammalian conceptus and goes on to form the majority of the components of the mature fetal placenta. Considerable controversy exists about what drives the specification of the trophoblast lineage, whether there is some degree of pre-patterning in the early cleavage stage conceptus or even the oocyte, and about how early in development the separation between the trophectoderm and embryonic lineages occurs [1], [2], [3], [4], [5]. Whichever view prevails, it is clear that trophectoderm precursor cells arise from pluripotent antecedents early in conceptus development.

In the human, two main cell lineages arise from the trophectoderm. One, villous cytotrophoblast, layers the basement membrane that surrounds placental villi. At these sites villous cytotrophoblast gives rise through division and fusion to syncytiotrophoblast [6], [7], a cell layer that makes direct contact with maternal blood and is characterized by the production of hCG and other placental hormones [8]. The second lineage derived from trophoblast stem cells is extravillous cytotrophoblast [9], which is non-polarized and multilayered, and the major invasive component of the placenta. These cells migrate in columns from the anchoring villi into the maternal endometrium by two routes: through the uterine stroma and via the lumen of maternal arteries [6] and play a variety of functions including support of the entire placental structure and modification of the spiral arteries [10]. Although the transcriptional programs that drive these events are beginning to be understood, experimental roadblocks exist to investigate how progenitor cells journey along these pathways of differentiation.

Back to Article Outline

2. Models to study trophoblast development 

Although many animal models, especially the mouse, can be used to follow trophoblast development from the blastocyst stage to the fully functional placenta, all show differences from the human [11]. In addition, only limited morphological information is available on the initial stages of trophoblast invasion, mainly from archived specimens [12]. Until recently the best in vitro models to study the development of human placenta have been choriocarcinoma-derived trophoblast cell lines, such as JAr or JEG3, and primary trophoblast cultures derived from the placenta either at term or earlier in pregnancy [13]. There are shortcomings and advantages to each of these models. Importantly, both choriocarcinoma cell lines and primary cytotrophoblast are already committed to trophoblast so that early lineage decisions cannot be addressed.

Many choriocarcinoma cell lines are available [14], [15]. These lines are easy to maintain, and share many characteristics with the primary trophoblast, including the ability to up-regulate hCG production in response to external stimuli, form a syncytium by cell fusion, and invade through an artificial connective tissue matrix. On the other hand, their behavior is often quite different from that of the primary trophoblast they are intended to mimic [16], [17], [18]. These occasional anomalies are probably due in part to their tumor cell origins. For example, primary trophoblasts transformed with SV40 show increased proliferative and invasive behavior compared to normal control cells [19], [20], [21], [22].

Primary human trophoblast cells, in contrast, better represent the behavior of normal human trophoblasts in vivo [23]. They have been used very effectively to elucidate key aspects of syncytiotrophoblast formation [24]. However, only primary cells derived from first trimester placentas will spontaneously form extravillous trophoblast [25], and such samples are not widely available for study.

Thus, the search continues for a model which, like choriocarcinoma cells, is readily available, easily maintained in the laboratory, and at the same time closely represents a normal trophoblast, particularly in its early commitment stages. Fortunately, human embryonic stem cells (hESC) have recently emerged as a useful alternative to other models and provide the potential to examine both the emergence of trophoblast from a precursor stem population and the subsequent differentiation of these cells. Among their advantages are: (1) they can be maintained indefinitely in the laboratory; (2) they do not suffer the disadvantages of being transformed; and (3) they provide the ability to study the initial embryonic/trophectoderm transition.

Back to Article Outline

3. hESC as models for trophoblast development 

ESC from primates, including the human, has been reported to differentiate into trophoblast spontaneously during standard subculture, as evidenced by the production of hCG (measured as hCGβ) and progesterone [26], [27], [28]. The former is probably not the most reliable of markers, as it is expressed by many human tumors that have no relationship to trophoblast [29]. Indeed, Ezashi et al. [30] have shown that, in spontaneously differentiating hESC colonies, the cells that produce hCGβ are small and quite unlike syncytiotrophoblast. They are also found on the periphery of emerging areas of larger flattened cells within the body of the colonies. Moreover, the hCGβ-positive cells do not co-express the hCGα sub-unit, suggesting that they are not producing bioactive hCG and are probably not the trophoblast.

On the other hand, hESC can be prompted to form the trophoblast. One approach is by the transgenic knockdown of genes associated with pluripotency. The second is culture of embryoid bodies (EB) in solid or semi-solid medium in the absence of factors that normally maintain pluripotency. The third is BMP4 treatment of stem cells cultured on Matrigel™.

The ability to drive differentiation of hESC towards trophoblast by silencing genes essential for maintaining pluripotency was first demonstrated in murine cells after the knockdown of Pou5F1 (Oct4) [31], [32], [33]. Silencing of NANOG or SOX2 also induces markers of trophoblast differentiation [34], [35], [36]. In hESC, siRNA silencing of POU5F1 followed by culture in the absence of FGF2 leads to apparent trophectoderm differentiation, with expression of BMP4, CDX2, CGA, CGB, EOMES, GATA2, GCM1, and ID2 [32], [37], [38]. A similar up-regulation of trophoblast markers and a transition in cell morphology were observed after NANOG silencing [39], although markers of extra-embryonic endoderm as well as those of trophoblast were increased. There is some evidence that mouse ESC can differentiate to trophoblast under certain conditions, but this process does not appear to occur as readily as in primate cells [40], [41]. Studies in the mouse have largely concentrated on trophoblast stem cells [42], whose equivalent has as yet not been reported for the human.

As an alternative to genetic manipulation, some investigators have attempted to collect spontaneously differentiating trophoblast from EBs, embryo-like structures formed from disaggregated hESC cultured in medium lacking growth factors that support pluripotency. EBs contain cells representative of all three embryonic lineages plus some peripheral cells with the properties of trophoblast [43], [44]. This model system has the advantage of developing in three dimensions and mimicking some of the features of blastocyst and trophectoderm formation and even the early stages of implantation.

Two strategies have been developed to purify trophoblast cells from EBs. In the first, EBs were disaggregated and clonal cell lines processed through several rounds of selection for high hCG production [45]. By this method, lines were developed that were able to proliferate indefinitely in culture but that did not express the “classical” embryonic stem cell markers NANOG and OCT4. The majority (although not all) of these cells expressed cytokeratin 7 and a minority the extravillous trophoblast markers HLA-G and CD9. If not passaged frequently, these cells spontaneously formed syncytia and began to secrete hCG. They could also form “trophoblast bodies”, structures morphologically similar to EBs, and were capable of invasion through artificial matrices in vitro [45].

A more recent approach to purify trophoblast cells from EBs has been based on the selection for adhesion rather than for hCG production [46]. hESC were cultured in a semi-solid, methylcellulose-containing medium. Over time in culture, they formed EBs. A PECAM-1 positive cell layer adhered firmly to the plastic and remained after EBs were removed by micro dissection. The adherent cells were almost all cytokeratin 7 and VE-cadherin positive, suggesting that they were extravillous trophoblast. Cells at the periphery of the outgrowths secreted hCG and stained positively with GB25, an antibody that recognizes syncytiotrophoblast and cytotrophoblast. Real-time PCR confirmed the down-regulation of pluripotent marker genes and the presence of transcripts for several additional trophoblast markers, including CDX2 and GATA2 [46].

A more directed conversion to trophoblast can be achieved in two-dimensional cultures when hESC are grown in the presence of growth factors belonging to the BMP family, especially BMP4, the most effective compound tested [47]. Addition of BMP4 between 10 and 100ng/ml led to the appearance of larger, more flattened cells at the periphery of the colonies. Over time a “wave of differentiation” progressed inwards towards the center of the colonies at a rate that was dependent on the BMP4 concentration [47], [48]. A parallel microarray analysis, performed at fixed times after the addition of BMP4 to H1 hESC, indicated an immediate up-regulation of genes encoding a group of transcription factors, some of which have been linked to trophoblast differentiation, e.g. GATA2, GATA3, MSX2, ID2. By 5 days the colonies strongly expressed a range of genes associated with differentiated trophoblast, e.g. CGA, CGB, MMP9, KRT7, and IGFBP3. Finally, when dissociated cells were plated at a low density in the presence of BMP4, some cells fused to form multinucleated patches of cells with a continuous cytoplasm that were positive for hCG. These areas of fused cells resembled syncytiotrophoblast [47]. It remained unclear whether the differentiation induced by BMP4 was unidirectional, i.e. directed entirely towards trophoblast, or whether other lineages arose within the colonies. In particular, by 24h there was an up-regulation of genes more typical of endoderm and placental yolk sac than of trophoblast, including the ones encoding alpha-fetoprotein (AFP), fibrinogen chains (FGA; FGG), apolipoprotein A4 (APOA4), transthyretin (TTR) and plasma retinol binding protein [47]. Thus, although hESC may serve as a model for studying extra-embryonic tissue development, there was a likelihood that BMP4 treatment led to the appearance of more than one lineage of cells.

Back to Article Outline

4. BMP4-driven differentiation of hESC in the absence of FGF2 at atmospheric and physiological O2 concentrations 

In the case of hESC, FGF2 is the crucial factor for sustaining proliferation and pluripotency, possibly through its ability to antagonize BMP signaling [49], although some recent evidence suggests that FGF2 up-regulates IGF2 and TGFβ production in FGFR-positive cells on the periphery of the colony and that these proteins are the “true” pluripotency factors required by the ES cells [50]. Whatever the role of FGF2 in maintaining “stemness”, its presence in the medium is likely to confound a study of BMP4-driven trophoblast differentiation. Accordingly our laboratory now omits FGF2 when testing BMP4 effects and has confirmed that 10ng/ml BMP4 can be used successfully to initiate trophoblast formation in H1 and H9 cells [51]. Since O2 tension is believed to influence both proliferation and differentiation of both villous and extravillous trophoblasts [52], [53], [54], we are also examining whether a reduction in O2 concentration from 20% to 4% influences the progressive differentiation of the hESC in response to BMP4. We have employed morphological criteria, hormone assays (hCG, progesterone), immunostaining for specific trophoblast lineage markers [51], and microarray analysis (unpublished data) to follow trophoblast differentiation in H1 and H9 colonies and made the following observations:

1.In the absence of FGF2, BMP drives differentiation unidirectionally towards trophoblast, unlike what is observed in EBs. A major difference from the study of Xu et al. [47] was that markers of endoderm formation were not up-regulated in our microarray studies (unpublished data).

2.During the initial 1–3 days of exposure to BMP4, cells in the center of colonies begin to pile up, possibly because they continue to divide in the space that is progressively restricted in area. The cells that ring this core demonstrate overt signs of morphological differentiation, taking on a flattened appearance (Fig. 1). However, they remain mitotically active and OCT4-positive, and they lack markers for differentiated trophoblast, such as cytokeratin 7 and 8 (Fig. 2B).
  • View full-size image.
  • Fig. 1 

    Phase contrast images showing the morphology of H1 hESC colonies cultured in the absence (a) or presence of 10ng/ml BMP4 for 3 (b, c) days. Cells were cultured in low (a, b) or atmospheric (c) oxygen, and in the presence (a) or absence (b, c) of FGF2. An area of morphologically differentiated cells, characterized by a cobblestone appearance, becomes visible at the periphery of the colony, and progresses inwards in cultures in which BMP4 was added (b, c). Central areas in b and c contain small, presumably undifferentiated cells, and appear quite similar to cells in a. BMP4-driven differentiation was slower under low oxygen. The scale bar shown in panel c represents 1mm.

  • View full-size image.
  • Fig. 2 

    Differentiation in BMP4 treated H9 hESC colonies proceeds from the periphery inward. (A) On day 5, cells at the periphery express syncytiotrophoblast marker hCGα (green) and hCGβ (red). Nuclei are counterstained with TO-PRO 3 (blue). (B) At day 6, cells in the core stain positively for pluripotency marker OCT4 (red), whereas the rest of the colony expresses the trophoblast marker cytokeratin 7 (green). Scale bars represent 500μm.

As noted by Xu et al. [47], we observed a decline in the expression of genes associated with pluripotency, e.g. POU5F1, NANOG, SOX2, and LEFTY2 over time, although the down-regulation was by no means immediate (Fig. 3). Interestingly, the expression of one gene, LEFTY2, was strongly influenced by the oxygen atmosphere under which the cells were cultured.
  • View full-size image.
  • Fig. 3 

    Changes in microarray expression (with values normalized to the median intensity of the array) for four genes associated with a pluripotent phenotype (POU5F1, NANOG, SOX2, and LEFTY2) and four genes that are regularly used as trophoblast markers (CGA, CGB5, KRT7, and KRT8). H1 hESC were exposed to BMP4 (10ng/ml) in either 4% (gray bar) or 20% (black bar) oxygen and collected after 0, 3, 12, 24, 72 and 120h. These data were obtained on Whole Human Genome Oligo microarrays (Agilent). Genes that were changing over time within each oxygen condition were identified by ANOVA. The genes shown here were selected from 33,814 genes of which 5194 changed expression more than 2-fold at P<0.01 in at least one time point. Changes in gene expression have been verified by real-time PCR with cDNA from H1 and H9 cells for POU5F1, NANOG, SOX2, LEFTY2, CGA, and CGB.


3.The acquisition of trophoblast differentiation markers, beginning on day 3, proceeds from the periphery towards the interior and is accelerated by about 24h in cultures under 20% O2 relative to those under 4% O2. By day 5, most of the cells outside the central core are positive for general trophoblast markers (Fig. 2B). Genes for these markers are also up-regulated (Fig. 3).

4.By day 5, regions contain sub-populations of cells strongly positive for markers of specialized trophoblast cell types (Fig. 2A). The hCG-positive cells are syncytial, with multiple nuclei in a continuous cytoplasm [51]. At day 5, hCG is secreted abundantly into the medium of hESC cultured under 20% but is almost undetectable under 4% [51]. Similar results were seen for expression of the CGA and CGB5 genes by microarray analysis (Fig. 3). Other colony regions stain brightly for HLA-G, generally considered a marker of extravillous cytotrophoblast [51]. Transcription factors such as GATA2 also show heterogeneous staining within the colonies, suggesting complex patterns of differentiation [51].

Back to Article Outline

5. Conclusions 

Together the above published and unpublished data indicate the potential usefulness of hESC grown in the presence of BMP4 and absence of FGF2 for studying both the emergence of trophoblast from hESC precursors and for its subsequent differentiation over time and space. A number of intriguing questions have arisen during the course of the studies so far. First, are the visibly differentiated, yet OCT4-positive, cells that immediately emerge in the periphery of the colonies treated with BMP4 equivalent to the trophoblast stem cell population? Are the strongly OCT4-positive cells remaining within the apparently undifferentiated “core” of the colonies still pluripotent, even after they have been exposed to BMP4 for several days? Why does differentiation proceed from the periphery towards the center of these colonies even though the entire colony is immersed in BMP4-containing medium? In this regard each colony appears to demonstrate “quorum sensing”, a phenomenon well known in colonies of microorganisms [55], [56] that must involve some form of chemical communication between individual cells within the colony. A final question is whether the transcription factors up-regulated immediately following BMP4 exposure are key to trophoblast lineage-decision making. These and other questions are currently being addressed in this laboratory.

Back to Article Outline

6. Conflict of interest 

The authors do not have any potential or actual personal, political, or financial interest in the material, information, or techniques described in this paper.

Back to Article Outline

Acknowledgements 

This research is supported by NIH grant HD042201. We thank Ms. Jessica Schlitt for technical assistance.

Back to Article Outline

References 

  1. Fleming TP. A quantitative analysis of cell allocation to trophectoderm and inner cell mass in the mouse blastocyst. Dev Biol. 1987;119:520–531
  2. Gardner RL. Specification of embryonic axes begins before cleavage in normal mouse development. Development. 2001;128:839–847
  3. Hiiragi T, Solter D. Mechanism of first cleavage specification in the mouse egg: is our body plan set at day 0?. Cell Cycle. 2005;4:661–664
  4. Johnson MH, McConnell JM. Lineage allocation and cell polarity during mouse embryogenesis. Semin Cell Dev Biol. 2004;15:583–597
  5. Zernicka-Goetz M. Developmental cell biology: cleavage pattern and emerging asymmetry of the mouse embryo. Nat Rev Mol Cell Biol. 2005;6:919–928
  6. Georgiades P, Ferguson-Smith AC, Burton GJ. Comparative developmental anatomy of the murine and human definitive placentae. Placenta. 2002;23:3–19
  7. Malassine A, Cronier L. Hormones and human trophoblast differentiation: a review. Endocrine. 2002;19:3–11
  8. Benirschke K. Anatomical relationship between fetus and mother. Ann N Y Acad Sci. 1994;731:9–20
  9. Bischof P, Campana A. Molecular mediators of implantation. Best Pract Res Clin Obstet Gynaecol. 2000;14:801–814
  10. Pijnenborg R. Implantation and immunology: maternal inflammatory and immune cellular responses to implantation and trophoblast invasion. Reprod Biomed Online. 2002;4(Suppl. 3):14–17
  11. Carter AM. Animal models of human placentation – a review. Placenta. 2007;28(Suppl. A):S41–S47
  12. Enders AC. Trophoblast–uterine interactions in the first days of implantation: models for the study of implantation events in the human. Semin Reprod Med. 2000;18:255–263
  13. Ringler GE, Strauss JF. In vitro systems for the study of human placental endocrine function. Endocr Rev. 1990;11:105–123
  14. King A, Thomas L, Bischof P. Cell culture models of trophoblast II: trophoblast cell lines–a workshop report. Placenta. 2000;21(Suppl. A):S113–S119
  15. Shiverick KT, King A, Frank H, Whitley GS, Cartwright JE, Schneider H. Cell culture models of human trophoblast II: trophoblast cell lines–a workshop report. Placenta. 2001;22(Suppl. A):S104–S106
  16. Graham CH, Connelly I, MacDougall JR, Kerbel RS, Stetler-Stevenson WG, Lala PK. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta. Exp Cell Res. 1994;214:93–99
  17. Hohn HP, Linke M, Ugele B, Denker HW. Differentiation markers and invasiveness: discordant regulation in normal trophoblast and choriocarcinoma cells. Exp Cell Res. 1998;244:249–258
  18. Zhang J, Cao YJ, Zhao YG, Sang QX, Duan EK. Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3. Mol Hum Reprod. 2002;8:659–666
  19. Khoo NK, Bechberger JF, Shepherd T, Bond SL, McCrae KR, Hamilton GS, et al. SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. I. Mechanisms responsible for hyperinvasiveness and resistance to anti-invasive action of TGFbeta. Int J Cancer. 1998;77:429–439
  20. Khoo NK, Zhang Y, Bechberger JF, Bond SL, Hum K, Lala PK. SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. II. Changes in gap junctional intercellular communication. Int J Cancer. 1998;77:440–448
  21. Lala PK, Lee BP, Xu G, Chakraborty C. Human placental trophoblast as an in vitro model for tumor progression. Can J Physiol Pharmacol. 2002;80:142–149
  22. Lee BP, Rushlow WJ, Chakraborty C, Lala PK. Differential gene expression in premalignant human trophoblast: role of IGFBP-5. Int J Cancer. 2001;94:674–684
  23. Frank HG, Morrish DW, Potgens A, Genbacev O, Kumpel B, Caniggia I. Cell culture models of human trophoblast: primary culture of trophoblast – a workshop report. Placenta. 2001;22(Suppl. A):S107–S109
  24. Aplin JD, Straszewski-Chavez SL, Kalionis B, Dunk C, Morrish D, Forbes K, et al. Trophoblast differentiation: progenitor cells, fusion and migration – a workshop report. Placenta. 2006;27(Suppl. A):S141–S143
  25. Genbacev O, Miller RK. Post-implantation differentiation and proliferation of cytotrophoblast cells: in vitro models – a review. Placenta. 2000;21(Suppl. A):S45–S49
  26. Draper JS, Pigott C, Thomson JA, Andrews PW. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat. 2002;200:249–258
  27. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–1147
  28. Thomson JA, Kalishman J, Golos TG, Durning M, Harris CP, Becker RA, et al. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A. 1995;92:7844–7848
  29. Iles RK. Ectopic hCGbeta expression by epithelial cancer: malignant behaviour, metastasis and inhibition of tumor cell apoptosis. Mol Cell Endocrinol. 2007;260–262:264–270
  30. Ezashi T, Das P, Roberts RM. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci U S A. 2005;102:4783–4788
  31. Velkey JM, O'Shea KS. Oct4 RNA interference induces trophectoderm differentiation in mouse embryonic stem cells. Genesis. 2003;37:18–24
  32. Hay DC, Sutherland L, Clark J, Burdon T. Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells. 2004;22:225–235
  33. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000;24:372–376
  34. Hough SR, Clements I, Welch PJ, Wiederholt KA. Differentiation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanog. Stem Cells. 2006;24:1467–1475
  35. Ivanova N, Dobrin R, Lu R, Kotenko I, Levorse J, DeCoste C, et al. Dissecting self-renewal in stem cells with RNA interference. Nature. 2006;442:533–538
  36. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet. 2006;38:431–440
  37. Babaie Y, Herwig R, Greber B, Brink TC, Wruck W, Groth D, et al. Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells. 2007;25:500–510
  38. Matin MM, Walsh JR, Gokhale PJ, Draper JS, Bahrami AR, Morton I, et al. Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells. 2004;22:659–668
  39. Hyslop L, Stojkovic M, Armstrong L, Walter T, Stojkovic P, Przyborski S, et al. Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells. 2005;23:1035–1043
  40. Hubner K, Kehler J, Scholer HR. Oocytes. Methods Enzymol. 2006;418:284–307
  41. Schenke-Layland K, Angelis E, Rhodes KE, Heydarkhan-Hagvall S, Mikkola HK, Maclellan WR. Collagen IV induces trophoectoderm differentiation of mouse embryonic stem cells. Stem Cells. 2007;25:1529–1538
  42. Rossant J. Stem cells and lineage development in the mammalian blastocyst. Reprod Fertil Dev. 2007;19:111–118
  43. Gerami-Naini B, Dovzhenko OV, Durning M, Wegner FH, Thomson JA, Golos TG. Trophoblast differentiation in embryoid bodies derived from human embryonic stem cells. Endocrinology. 2004;145:1517–1524
  44. Golos TG, Pollastrini LM, Gerami-Naini B. Human embryonic stem cells as a model for trophoblast differentiation. Semin Reprod Med. 2006;24:314–321
  45. Harun R, Ruban L, Matin M, Draper J, Jenkins NM, Liew GC, et al. Cytotrophoblast stem cell lines derived from human embryonic stem cells and their capacity to mimic invasive implantation events. Hum Reprod. 2006;21:1349–1358
  46. Peiffer I, Belhomme D, Barbet R, Haydont V, Zhou YP, Fortunel NO, et al. Simultaneous differentiation of endothelial and trophoblastic cells derived from human embryonic stem cells. Stem Cells Dev. 2007;16:393–402
  47. Xu RH, Chen X, Li DS, Li R, Addicks GC, Glennon C, et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol. 2002;20:1261–1264
  48. Liu YP, Dovzhenko OV, Garthwaite MA, Dambaeva SV, Durning M, Pollastrini LM, et al. Maintenance of pluripotency in human embryonic stem cells stably over-expressing enhanced green fluorescent protein. Stem Cells Dev. 2004;13:636–645
  49. Xu RH, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods. 2005;2:185–190
  50. Bendall SC, Stewart MH, Menendez P, George D, Vijayaragavan K, Werbowetski-Ogilvie T, et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature. 2007;448:1015–1021
  51. Das P, Ezashi T, Schulz LC, Westfall SD, Livingston KA, Roberts RM. Effects of FGF2 and oxygen in the BMP4-driven differentiation of trophoblast from human embryonic stem cells. Stem Cell Res 2007; in press.
  52. Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SJ. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest. 1996;97:540–550
  53. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science. 1997;277:1669–1672
  54. James JL, Stone PR, Chamley LW. The effects of oxygen concentration and gestational age on extravillous trophoblast outgrowth in a human first trimester villous explant model. Hum Reprod. 2006;21:2699–2705
  55. Shapiro JA. Thinking about bacterial populations as multicellular organisms. Annu Rev Microbiol. 1998;52:81–104
  56. Whitehead NA, Barnard AM, Slater H, Simpson NJ, Salmond GP. Quorum-sensing in Gram-negative bacteria. FEMS Microbiol Rev. 2001;25:365–404

PII: S0143-4004(07)00258-5

doi:10.1016/j.placenta.2007.10.009

Placenta
Volume 29, Supplement , Pages 10-16, March 2008

Article Tools

* Image Usage & Resolution